BeStock  
Stocks › Biotechnology › FTH

Faeth Therapeutics FTH

US equityMarket cap rank #3571Biotechnology
$24.92 −$1.97 (-7.33%)
Market closed · Oct 8, 7:00 am ET · Last extended-hours $24.92 0.00%
Open$26.71
Prev close$26.89
Day range$23.95 – $27.03
Volume322.6K
Market cap$643.94M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-0.4x
CheapRich

Near the top of its 5-year range · 95th percentile, 5-year average -2.3x

Price / book3.7x
CheapRich

Near the top of its 5-year range · 95th percentile, 5-year average 0.5x

#3965 of 5317 stocks by PB (1 = cheapest)

P/E over five years

-22x-14x-5x3xOct '21May '23Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$51.69
Price vs. fair value-51.8%Trading below the estimate
Star rating★★★★★
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.72 – 0.52 95% (pricier than usual) #3965 of 5317 (1 = cheapest)
PE -0.41 -7.61 -2.29 95% (pricier than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★★★
Fair value estimate$51.69
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on FTH.

Leave a comment

Scroll to Top